AB003. Urinary microRNAs of prostate cancer.

Background MicroRNAs (miRNAs) may be potential cancer biomarkers as stable miRNAs have been detected in biological fluids such as serum, plasma, and urine. The aims of the study were to investigate whether expression of urinary cell-free miRNAs is different in prostate cancer (CaP) patients and patients with benign prostatic hyperplasia (BPH).